Research Activity
Abcam Joins Innovative Health Initiative LIGAND-AI Project to Advance AI-Driven Drug Discovery
Abcam; LIGAND-AI; Innovative Health Initiative; AI-driven drug discovery; open science; protein-ligand datasets
Makary Proposes Higher FDA User Fees for Non-US Phase I Trials to Counter China Biotech
Makary; FDA; user fees; China; biotech; Phase I trials; America First
AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Trial of AAVB-081 for Usher Syndrome Type 1B-Associated Retinitis Pigmentosa
AAVantgarde; LUCE-1; AAVB-081; Usher Syndrome Type 1B; USH1B; retinitis pigmentosa; gene therapy; clinical trial
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff
Pfizer; Obesity Drugs; Metsera; Phase III Trials; Albert Bourla; JPM26; Patent Cliff
Eli Lilly and Nvidia Announce $1 Billion, Five-Year AI Co-Innovation Lab Partnership in Bay Area
Eli Lilly; Nvidia; AI lab; drug discovery; $1 billion; Bay Area; JPM 2026
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
Moleculin; MIRACLE trial; Annamycin; WP1066; AML; clinical trials; 2026 milestones
Dr Melanie Ivarsson Appointed CEO of Health Data Research Service
Dr Melanie Ivarsson; Health Data Research Service; HDRS; CEO appointment; UK health data; medical research
Insilico Medicine and Servier Announce Up to $888 Million AI-Driven Oncology R&D Collaboration
Insilico Medicine; Servier; AI platform; oncology; drug discovery; Pharma.AI; $888 million
Genelux Corporation Appoints Jason Litten, M.D., as Chief Medical Officer to Advance Olvi-Vec Development
Genelux Corporation; Jason Litten; Chief Medical Officer; CMO; Olvi-Vec; immuno-oncology; clinical trials
Insilico Medicine Caps 2025 with Record HKD 2.277 Billion Hong Kong IPO
Insilico Medicine; Hong Kong IPO; AI biotech; HKEX listing; drug discovery